Description
Empagliflozin, linagliptin, and metformin combination is used with proper diet and exercise to lower high blood sugar levels caused by type 2 diabetes. It is also used to lower the risk of death in patients with type 2 diabetes and heart disease.
Additional information
| brand | Pharmevo (Private) |
|---|
